CP:TSXCanadian Pacific Kansas City Limited Analysis
Data as of 2026-03-10 - not real-time
CA$113.92
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Canadian Pacific Kansas City (CP.TO) is trading at C$113.92, comfortably above its 20‑day SMA of C$116 (just below the 50‑day SMA) and well above the 200‑day SMA, indicating a bullish price structure. The stock is sitting on a technical support around C$108.7 and faces resistance near C$122.3, while volume has been increasing and the 30‑day volatility is roughly 27%, suggesting active market participation. Momentum indicators are mixed – the RSI sits near the midpoint at 51, and the MACD histogram is negative, signaling a short‑term bearish tilt despite an overall bullish trend direction. The market sentiment is in the “Extreme Greed” zone (Fear & Greed Index 75.9), which aligns with the recent 6.8% weekly gain and the recent record grain shipments reported in the news.
Fundamentally, CP delivers strong operating margins (44% operating, 27% net) and a modest revenue growth of 1.3%. Its PE of ~25 is below the industry average of ~30, and the forward PE of ~19 suggests earnings expansion ahead. The dividend yield of ~0.8% with a low payout ratio (~19%) appears sustainable given robust operating cash flow and free cash flow. However, the company carries a sizable debt load (≈C$23.6 bn) and a DCF‑derived fair value of only C$6.5, implying a significant overvaluation gap. Recent news of a US$1.2 bn debt offering underscores the need to monitor leverage, while the record grain volumes highlight operational strength.
Fundamentally, CP delivers strong operating margins (44% operating, 27% net) and a modest revenue growth of 1.3%. Its PE of ~25 is below the industry average of ~30, and the forward PE of ~19 suggests earnings expansion ahead. The dividend yield of ~0.8% with a low payout ratio (~19%) appears sustainable given robust operating cash flow and free cash flow. However, the company carries a sizable debt load (≈C$23.6 bn) and a DCF‑derived fair value of only C$6.5, implying a significant overvaluation gap. Recent news of a US$1.2 bn debt offering underscores the need to monitor leverage, while the record grain volumes highlight operational strength.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above key moving averages and holding support
- Increasing volume and bullish trend direction
- Technical momentum still near neutral, offering upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong operating margins and cash flow generation
- Dividend sustainability with low payout ratio
- Upside potential of ~7% versus current price
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt level and DCF fair value indicating overvaluation
- Stable core business across Canada, US and Mexico
- Exposure to regulatory and commodity cycle risks
Key Metrics & Analysis
Financial Health
Revenue Growth1.30%
Profit Margin27.46%
P/E Ratio25.0
ROE8.64%
ROA4.39%
Debt/Equity50.40
P/B Ratio2.2
Op. Cash FlowCA$5.3B
Free Cash FlowCA$2.0B
Industry P/E29.5
Technical Analysis
TrendBullish
RSI51.6
SupportCA$108.67
ResistanceCA$122.25
MA 20CA$116.00
MA 50CA$107.16
MA 200CA$105.69
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair ValueCA$6.52
Target PriceCA$121.55
Upside/Downside6.70%
GradeOvervalued
TypeBlend
Dividend Yield0.81%
Risk Assessment
Beta0.66
Volatility27.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.